Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials

Current pharmacological therapies for heart failure with reduced ejection fraction are largely either repurposed anti‐hypertensives that blunt overactivation of the neurohormonal system or diuretics that decrease congestion. However, they do not address the symptoms of heart failure that result from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Tariq, Miller, P. Elliott, McCullough, Megan, Desai, Nihar R., Riello, Ralph, Psotka, Mitchell, Böhm, Michael, Allen, Larry A., Teerlink, John R., Rosano, Giuseppe M.C., Lindenfeld, Joann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774302/
https://www.ncbi.nlm.nih.gov/pubmed/31407860
http://dx.doi.org/10.1002/ejhf.1557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774302/
https://www.ncbi.nlm.nih.gov/pubmed/31407860
http://dx.doi.org/10.1002/ejhf.1557

Ejemplares similares